Switch to:
Array BioPharma Inc (NAS:ARRY)
Research and Development
$160.7 Mil (TTM As of Jun. 2016)

This is the expense the company spent on research and development. Array BioPharma Inc's research and development for the three months ended in Jun. 2016 was $49.5 Mil. Its research and development for the trailing twelve months (TTM) ended in Jun. 2016 was $160.7 Mil.


Definition

This is the expense the company spent on research and development.

Array BioPharma Inc Research & Development for the trailing twelve months (TTM) ended in Jun. 2016 was 20.998 (Sep. 2015 ) + 41.351 (Dec. 2015 ) + 48.802 (Mar. 2016 ) + 49.504 (Jun. 2016 ) = $160.7 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Array BioPharma Inc Annual Data

Jun07Jun08Jun09Jun10Jun11Jun12Jun13Jun14Jun15Jun16
Research & Development 57.590.389.672.563.556.759.449.854.4160.7

Array BioPharma Inc Quarterly Data

Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16
Research & Development 14.512.211.811.818.621.041.448.849.546.6
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK